Mirta Acuña
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mirta Acuña has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
Dona Benadof
Hospital Roberto del Río, Santiago, Chile
3 shared publications- Claudio González Muñoz
QF. Clínico, Hospital Exequiel González Cortez
2 shared publications Daniela Pavez Azurmendi
Pediatra Infectóloga, Hospital San Juan de Dios, Clínica Alemana de Santiago, Universidad de Chile
2 shared publications- Dona Benadof
Hospital Roberto del Rio, Santiago 8380457, Chile
2 shared publications - Fernando Bernal Ortiz
QF. Clínico, Hospital San Juan de Dios
2 shared publications - Jorge Pérez Godoy
11Médico Infectólogo, Hospital Padre Hurtado, Clínica Alemana de Santiago, Facultad de Medicina Clínica Alemana-Universidad del Desarrollo
2 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (3) , 247
Antimicrobial Stewardship Programs in Chile: A Historical Overview
Antimicrobial Stewardship Programs (ASPs) are a cornerstone strategy to mitigate the global threat of antimicrobial resistance (AMR), primarily driven by inappropriate antimicrobial use. ASPs aim to optimize antimicrobial therapy by ensuring appropriate indication, agent selection, dosing, route of administration, and duration of treatment. Through these interventions, ASPs improve clinical outcomes, reduce adverse drug events, decrease selective pressure for resistant organisms, and contribute to healthcare cost containment. Effective implementation requires a multidisciplinary approach involving physicians, pharmacists, microbiologists, nurses, and information technology specialists, and must be tailored to local epidemiology and healthcare system capacity in accordance with World Health Organization (WHO) recommendations. This narrative review describes the development and evolution of the national antimicrobial stewardship policy in Chile, based on a review of publications indexed in SciELO, official documents from the Ministry of Health (MINSAL), and relevant national legislation. In Chile, antimicrobial stewardship initiatives began in the late 1990s with regulatory measures mandating prescription-only dispensing of antimicrobials and the introduction of national technical standards for rational antimicrobial use. After that, Chile adopted a comprehensive One Health approach and implemented national AMR action plans aligned with WHO strategies. Substantial progress has been achieved across hospital, primary care, veterinary, and aquaculture settings, including expanded ASP coverage, strengthened regulatory frameworks, national surveillance systems for antimicrobial consumption and resistance, and incorporation of stewardship indicators into institutional performance metrics. Despite these advances, challenges related to workforce capacity, technological infrastructure, and long-term monitoring persist and must be addressed to further consolidate national ASP implementation.
- 27 February 2026
- Published by MDPI AG in Antibiotics
- Vol. 15 (3) , 247
Open AccessAntimicrobial Stewardship Programs in Chile: A Historical Overview
Antimicrobial Stewardship Programs (ASPs) are a cornerstone strategy to mitigate the global threat of antimicrobial resistance (AMR), primarily driven by inappropriate antimicrobial use. ASPs aim to optimize antimicrobial therapy by ensuring appropriate indication, agent selection, dosing, route of administration, and duration of treatment. Through these interventions, ASPs improve clinical outcomes, reduce adverse drug events, decrease selective pressure for resistant organisms, and contribute to healthcare cost containment. Effective implementation requires a multidisciplinary approach involving physicians, pharmacists, microbiologists, nurses, and information technology specialists, and must be tailored to local epidemiology and healthcare system capacity in accordance with World Health Organization (WHO) recommendations. This narrative review describes the development and evolution of the national antimicrobial stewardship policy in Chile, based on a review of publications indexed in SciELO, official documents from the Ministry of Health (MINSAL), and relevant national legislation. In Chile, antimicrobial stewardship initiatives began in the late 1990s with regulatory measures mandating prescription-only dispensing of antimicrobials and the introduction of national technical standards for rational antimicrobial use. After that, Chile adopted a comprehensive One Health approach and implemented national AMR action plans aligned with WHO strategies. Substantial progress has been achieved across hospital, primary care, veterinary, and aquaculture settings, including expanded ASP coverage, strengthened regulatory frameworks, national surveillance systems for antimicrobial consumption and resistance, and incorporation of stewardship indicators into institutional performance metrics. Despite these advances, challenges related to workforce capacity, technological infrastructure, and long-term monitoring persist and must be addressed to further consolidate national ASP implementation.
- Open Access
Evaluating the Clinical Impact of BioFire Spotfire R/ST on the Management of Pediatric Respiratory Presentations in the Emergency Department: A Pre–Post Cross-Sectional Study in Chile
Respiratory infections represent one of the leading causes of pediatric consultations and hospitalizations in Chile, where rapid etiological identification is essential for clinical decision-making. We evaluated the impact of implementing the BIOFIRE® SPOTFIRE® Respiratory (R) Panel in the pediatric Emergency Department of a public referral hospital in Santiago, using a pre–post cross-sectional design comparing two winter periods (July 2023 vs. July 2024). Clinical records, laboratory data, and operational indicators were analyzed to assess changes in diagnostic yield, turnaround time, hospitalizations, discharges, supplementary test requests, and antimicrobial use. A total of 470 patients were included (224 in 2023; 246 in 2024). The etiological detection rate increased from 58.0% to 87.8% after the implementation of Spotfire® (p < 0.0001), with marked increases in the identification of adenovirus, RSV, rhinovirus/enterovirus, and seasonal coronaviruses. Rapid molecular testing was associated with a significant rise in emergency department discharges (23.7% vs. 57.3%; p < 0.0001) and a reduction in hospitalizations (76.3% vs. 42.7%; p < 0.0001) and readmissions (9.2% vs. 0.5%; p < 0.0001). Requests for complete blood counts, chest X-rays, and antimicrobial prescriptions at discharge also decreased significantly. These effects persisted in key subgroups, including infants and children with comorbidities. In this high-demand winter setting, the BIOFIRE® SPOTFIRE® R Panel improved diagnostic performance and supported more efficient and targeted clinical management.
Open AccessEvaluating the Clinical Impact of BioFire Spotfire R/ST on the Management of Pediatric Respiratory Presentations in the Emergency Department: A Pre–Post Cross-Sectional Study in Chile
Respiratory infections represent one of the leading causes of pediatric consultations and hospitalizations in Chile, where rapid etiological identification is essential for clinical decision-making. We evaluated the impact of implementing the BIOFIRE® SPOTFIRE® Respiratory (R) Panel in the pediatric Emergency Department of a public referral hospital in Santiago, using a pre–post cross-sectional design comparing two winter periods (July 2023 vs. July 2024). Clinical records, laboratory data, and operational indicators were analyzed to assess changes in diagnostic yield, turnaround time, hospitalizations, discharges, supplementary test requests, and antimicrobial use. A total of 470 patients were included (224 in 2023; 246 in 2024). The etiological detection rate increased from 58.0% to 87.8% after the implementation of Spotfire® (p < 0.0001), with marked increases in the identification of adenovirus, RSV, rhinovirus/enterovirus, and seasonal coronaviruses. Rapid molecular testing was associated with a significant rise in emergency department discharges (23.7% vs. 57.3%; p < 0.0001) and a reduction in hospitalizations (76.3% vs. 42.7%; p < 0.0001) and readmissions (9.2% vs. 0.5%; p < 0.0001). Requests for complete blood counts, chest X-rays, and antimicrobial prescriptions at discharge also decreased significantly. These effects persisted in key subgroups, including infants and children with comorbidities. In this high-demand winter setting, the BIOFIRE® SPOTFIRE® R Panel improved diagnostic performance and supported more efficient and targeted clinical management.
- Open Access
- 1 December 2020
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 37 (6) , 646-666
Recomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19)
- 1 December 2020
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 37 (6) , 646-666
Open AccessRecomendaciones para el estudio y manejo farmacológico en pacientes adultos con sospecha de infección por SARS-CoV-2 (COVID-19)
- Open Access
- 1 December 2020
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 37 (6) , 625-645
Recomendaciones para el diagnóstico y manejo farmacológico en pacientes pediátricos con infección por SARS-CoV-2 (COVID-19)
- 1 December 2020
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 37 (6) , 625-645
Open AccessRecomendaciones para el diagnóstico y manejo farmacológico en pacientes pediátricos con infección por SARS-CoV-2 (COVID-19)
- Open Access
- 1 February 2016
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 33 (1) , 75-78
Mediastinitis por Aspergillus fumigatus en un paciente pediátrico inmunocompetente posterior a una cardiocirugía
Postsurgical aspergillosis occurs primarily in immunocompetent patients whose main predisposing factor is the loss of skin and mucosal integrity during surgery. Local infection tends to be destructive and refractory to treatment and relapses are common. It is important to consider aspergillosis in the differential diagnosis of slowly progressive and destructive surgical site infections with negative bacterial cultures. We present the case of a child who developed Aspergillus fumigatus mediastinitis months after heart surgery.
- 1 February 2016
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 33 (1) , 75-78
Open AccessMediastinitis por Aspergillus fumigatus en un paciente pediátrico inmunocompetente posterior a una cardiocirugía
Postsurgical aspergillosis occurs primarily in immunocompetent patients whose main predisposing factor is the loss of skin and mucosal integrity during surgery. Local infection tends to be destructive and refractory to treatment and relapses are common. It is important to consider aspergillosis in the differential diagnosis of slowly progressive and destructive surgical site infections with negative bacterial cultures. We present the case of a child who developed Aspergillus fumigatus mediastinitis months after heart surgery.
- Open Access
- 1 August 2015
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 32 (4) , 393-398
Factores de riesgo de colonización por Enterococcus spp resistente a vancomicina en pacientes pediátricos hospitalizados con patología oncológica
The isolation of vancomycin-resistant Enterococcus spp (ERV) has increased significantly within the last few years, along with the risk of infection and dissemination of these bacteria. Our aim was to determine risk factors (RF) for intestinal colonization in hospitalized pediatric patients with oncological disease at Hospital de Niños Roberto del Río. Between January 2012 and December 2013 a transversal study was performed with 107 rectal swabs and processed with a PCR for ERV. The patients were classified as "colonized with ERV" and "not colonized with ERV" and we evaluated possible RF for intestinal colonization in both groups. VRE colonization was found in 51 patients (52%). The median of time elapsed between oncological diagnosis and VRE colonization was 35 days. The significant RF associated with VRE colonization were days of hospitalization prior to study, neutropenia and treatment with antibiotics within 30 days prior to study and mucositis. According to the RF revealed in this study we may suggest prevention standards to avoid ERV colonization. This is the first investigation in our country in hospitalized pediatric patients with oncological disease and processed with a multiplex PCR for ERV, therefore it is a great contribution about this subject in Chile.
- 1 August 2015
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 32 (4) , 393-398
Open AccessFactores de riesgo de colonización por Enterococcus spp resistente a vancomicina en pacientes pediátricos hospitalizados con patología oncológica
The isolation of vancomycin-resistant Enterococcus spp (ERV) has increased significantly within the last few years, along with the risk of infection and dissemination of these bacteria. Our aim was to determine risk factors (RF) for intestinal colonization in hospitalized pediatric patients with oncological disease at Hospital de Niños Roberto del Río. Between January 2012 and December 2013 a transversal study was performed with 107 rectal swabs and processed with a PCR for ERV. The patients were classified as "colonized with ERV" and "not colonized with ERV" and we evaluated possible RF for intestinal colonization in both groups. VRE colonization was found in 51 patients (52%). The median of time elapsed between oncological diagnosis and VRE colonization was 35 days. The significant RF associated with VRE colonization were days of hospitalization prior to study, neutropenia and treatment with antibiotics within 30 days prior to study and mucositis. According to the RF revealed in this study we may suggest prevention standards to avoid ERV colonization. This is the first investigation in our country in hospitalized pediatric patients with oncological disease and processed with a multiplex PCR for ERV, therefore it is a great contribution about this subject in Chile.
- Open Access
- 1 June 2015
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 32 (3) , 350-356
Staphylococcus aureus resistente a meticilina asociado a la comunidad (SARM-AC): comunicación de los primeros cuatro casos pediátricos descritos en Hospital de Niños Roberto del Río
Staphylococcus aureus is a known pathogen in pediatric patients that produces skin infections, cutaneous abscess, cellulitis and osteoarticular infections. Most of these infections are produced by a meticilin susceptible strain. The community associated methicillin resistant Staphylococcus aureus was published for the first time in 1993, ever since then is has been recognized as a cosmopolite pathogen. The first report in Latin America was published in 2003, and in Chile in 2008 from adult patients that have reported traveling to other countries. The following series describes four pediatric cases, all school-aged children, diagnosed since 2012 with clinical followups and molecular studies. Two cases presented as osteomyelitis of the lower extremity; and one presented as arm cellulitis. These three cases had Panton Valentine leukocidine (PV-L) negative strains from the clone complex 8. The last case presented a renal abscess, the strain was PV-L positive from the clone complex 30. This case series constitutes the first pediatric case report in Chile.
- 1 June 2015
- Published by SciELO Agencia Nacional de Investigacion y Desarrollo (ANID) in Revista chilena de infectología
- Vol. 32 (3) , 350-356
Open AccessStaphylococcus aureus resistente a meticilina asociado a la comunidad (SARM-AC): comunicación de los primeros cuatro casos pediátricos descritos en Hospital de Niños Roberto del Río
Staphylococcus aureus is a known pathogen in pediatric patients that produces skin infections, cutaneous abscess, cellulitis and osteoarticular infections. Most of these infections are produced by a meticilin susceptible strain. The community associated methicillin resistant Staphylococcus aureus was published for the first time in 1993, ever since then is has been recognized as a cosmopolite pathogen. The first report in Latin America was published in 2003, and in Chile in 2008 from adult patients that have reported traveling to other countries. The following series describes four pediatric cases, all school-aged children, diagnosed since 2012 with clinical followups and molecular studies. Two cases presented as osteomyelitis of the lower extremity; and one presented as arm cellulitis. These three cases had Panton Valentine leukocidine (PV-L) negative strains from the clone complex 8. The last case presented a renal abscess, the strain was PV-L positive from the clone complex 30. This case series constitutes the first pediatric case report in Chile.
- Open Access
- 1 June 2011
- Published by Sociedad Chilena de Pediatria in Revista chilena de pediatría
- Vol. 82 (3) , 198-203
Antibióticos y expresión de betalactamasas de espectro extendido (BLEE) en agentes bacterémicos
- 1 June 2011
- Published by Sociedad Chilena de Pediatria in Revista chilena de pediatría
- Vol. 82 (3) , 198-203
Open AccessAntibióticos y expresión de betalactamasas de espectro extendido (BLEE) en agentes bacterémicos